Please note: The information displayed on this page might be outdated.
Zikani Therapeutics: Zikani Therapeutics is using its innovative chemistry technology platform to develop novel Ribosome Modulating Agents (RMAs). We are focused on developing and commercializing therapeutics for patients with limited treatment options.

Zikani’s TURBO-ZM platform allows rapid synthesis of novel compounds that can be optimized to modulate the human ribosome in a disease specific manner.
Sector/Industry:
Healthcare
Characteristics:
Based in...
US - New England
Clinical Stage
Pre-Clinical Stage
Disease Space
Oncology, Rare Disease
Listing
Private
Website:
Profiles:
Address:
480 Arsenal Way
Suite 130
Watertown, MA 02472
United States

Company Participants at Summer 2020 NYC Private Company Showcase

  • Sumit Aggarwal, CEO
  • Vijay Modur, Head of R&D